Trim 50% of SPCX long exposure into 7% breakout pop on 119M volume at $155-160, retain 50% residual with $143.77 stop
Unanimous analyst consensus to trim is anchored in structural evidence: 91x forward P/E and 91x sales at current levels, FCF deteriorating 5x (-$3.22B to -$16.82B), Capex of $18.37B vs OCF of $2.42B (16.8x coverage gap), merger probability 16% (-2.5pp WoW), bearish technical divergence (death cross structure, MACD histogram lower-highs vs price higher-highs), and 96-97% no-cut macro headwind. The 50% trim applies the NFLX high-beta lesson (50-60%+ trim to extract alpha on high-beta instruments with ATR of $6.38) while preserving asymmetric participation in operational catalysts the reflection protects. The $143.77 stop at 200 SMA avoids whipsaw risk of tighter $148-150 stop (where all other traders are setting stops). The 10/1 reflection's deliberate middle path is a directional execution calibration (sell the momentum pop), not a magnitude-synthesis artifact. Measured downside target is $135 (between 50 SMA at $138.96 and $130 institutional floor) if thesis plays out.
| Position | Action |
|---|---|
| Entry zone $155-160 | Trim 50% total (30% Tranche 1 at $155-157, 20% Tranche 2 at $158-160, optional 10% Tranche 3 above $160 on exhaustion) |
| Daily close below $130 on volume >70M | Cut residual by additional 25% (position now ~25%) |
| Daily close below $108-115 (August base) | Full exit residual |
| Daily close above $170 on volume >100M | Scale back toward 65-75% of pre-trim position |
| Starship reusability probability crosses 50% | Scale back toward 65-75% of pre-trim position |
| Q3 2026 print with sequential revenue >$6B AND OCF sustained positive AND gross margin >50% | Reassess to Hold/Overweight, scale toward 65-75% of pre-trim position |
| Fed dovish pivot OR 10Y breaks below 4.50% | Scale back toward 65-75% of pre-trim position |
SPCX is at an operational inflection with 92% revenue growth and 1,100bps margin expansion, technically breaking out on institutional volume with $93.5B in cash providing multi-year runway—the confirmation of the breakout IS the opportunity, not something to wait for.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $150.87 | bullish |
| 50 SMA | $138.96 | neutral |
| 200 SMA | $143.77 | bullish |
| RSI(14) | 61.37 | bullish |
| MACD | 2.77 | bullish |
| MACD Signal | 2.87 | bullish |
| MACD Histogram | -0.11 | bearish |
| ATR(14) | $6.77 | neutral |
| Bollinger Upper Band (20 SMA) | $157.29 | bullish |
| Bollinger Middle Band (20 SMA) | $150.13 | neutral |
| Bollinger Lower Band (20 SMA) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price reaches $155-157
Then: Sell 30% of position
EV: +21% (target $192.50 vs. current $158.96) · concedes: The 91x forward P/E is rich on near-term earnings (though reasonable on 3-5 year TAM view); FCF burn of -$16.8B/quarter is substantial (though a deliberate choice funded by $93.5B cash, not a distress signal); 96% no-cut probability is already priced in (though any dovish surprise would be a tailwind); MACD histogram turned negative at -0.11 (though MACD line still positive at +2.77 and this is a momentum reset, not regime change); 50 SMA still below 200 SMA (though curling higher and golden cross is weeks away, not months)
SPCX's 7% pop is a trap, not a triumph — the valuation is parabolic, cash burn is accelerating, technicals show a confirmed bear flag, catalysts are fading, and the risk/reward is asymmetric to the downside.
EV: -32% · concedes: Q2 2026 revenue of $7.81B with 92% YoY growth is real; EBITDA did inflect from -$1.16B to +$2.96B; The $85.7B equity raise provides runway; Starship reusability odds did tick up 3.5pp; Technical stop on bull's own report is $149.30 — only 6% above current
→ vs conservative: Cash position of $93.5 billion signals runway to continue burning money, not operational success; the company needed to raise $85 billion equity to survive the buildout
→ vs conservative: One quarter of positive OCF ($2.42B) against capex of $18.37B ignores the $16 billion gap; OCF inflection thesis is selectively reading data
→ vs conservative: Volume confirmation on one day of 119 million shares does not override four weeks of MACD histogram weakness into overbought Bollinger extension at resistance
→ vs neutral: Waiting for confirmation above $160 is closer to bearish view than bullish, but aggressive version is to act now into strength rather than wait; trim into pop on heavy volume
→ vs conservative: Tesla-SpaceX merger catalyst at 16% probability is bleeding out; Starship reusability at 28% is 2027 event not justifying 91x forward earnings today
| $142.97 |
| neutral |
| Volume | 119.27M shares | bullish |
| Average Volume (3-week) | ~70M shares | neutral |
Support: 157.29 · 150.87 · 150 · 143.77 · 138.96 · 142.97 | Resistance: 159.84 · 162 · 165 · 192.5
The technical picture shows a confirmed breakout with price closing above all three moving averages and substantially above average volume, but the 50 SMA remains below the 200 SMA (lingering bearish configuration) and the MACD histogram turned mildly negative, indicating momentum divergence. RSI has room before overbought territory, and ATR compression suggests a volatility squeeze ahead of the expansion event. Tactical bias is bullish with risk management discipline warranted; a pullback to $150–$152 would offer attractive scaled entry opportunities.
Market Cap
$2,095.38B
Forward P/E
91.19x
Price / Book
16.46x
EPS (TTM)
-$1.10
Forward EPS
$1.74
52-Week High
$225.64
52-Week Low
$104.83
50-Day Avg
$138.14
200-Day Avg
$143.57
Book Value / Share
$9.66
Revenue (TTM)
$23.04B
Revenue Q2 2026
$7.81B
Revenue Q1 2026
$4.69B
Gross Profit (TTM)
$11.95B
Gross Margin (TTM)
51.9%
Gross Margin Q2 2026
55.3%
EBITDA (TTM)
$5.90B
EBITDA Q2 2026
$2.96B
Net Income (TTM)
-$8.89B
Net Income Q2 2026
-$541M
Diluted EPS Q2 2026
-$0.09
D&A (quarterly)
$2.85B
Interest Expense (quarterly)
$629M
R&D (Q2 2026)
$3.55B
Total Assets (Q2 2026)
$192.77B
Cash & Equivalents (Q2 2026)
$93.52B
Total Debt (Q2 2026)
$39.71B
Long-Term Debt (Q2 2026)
$36.84B
Current Debt (Q2 2026)
$2.53B
Stockholders' Equity (Q2 2026)
$127.22B
Net Tangible Assets
$113.18B
Current Ratio
5.12
Debt / Equity
31.21x
Retained Earnings
-$41.85B
Net PPE
$66.85B
Construction In Progress
$12.55B
Operating Cash Flow (Q2 2026)
+$2.42B
Capex (Q2 2026)
-$18.37B
Free Cash Flow (Q2 2026)
-$16.82B
Stock Issued (Q2 2026)
+$85.68B
End Cash (Q2 2026)
$94.35B
Shares Outstanding (Q2 2026)
13.176B
Diluted Share Count (Q2 2026)
5.864B
Diluted Share Count (Q1 2026)
10.607B
Revenue YoY Growth
+92%
R&D YoY Growth
+81%
Capex YoY Growth
+549%
Net Debt (Q1 2026)
$14.41B
Preferred Stock
$0
Strengths
Concerns
SPCX is a high-growth aerospace company trading at 91x forward P/E and 16.5x P/B, having just completed a massive $85.68B equity raise that transformed its balance sheet to $93.5B cash while eliminating net debt. The business is operationally inflecting with Q2 2026 revenue up 92% YoY to $7.81B, gross margins expanding to 55.3%, and operating cash flow turning positive at $2.42B, though GAAP losses of -$541M persist due to $2.85B in quarterly depreciation and $629M in interest expense. Free cash flow burn of $16.82B/quarter remains substantial despite the capital raise, and the stock trades below its 200-day moving average after retreating from $225.64, suggesting a HOLD bias pending further execution evidence.
Macro: The dominant macro theme is a hawkish Fed caught between no rate cuts (96% probability) and an Iran-conflict inflation shock, creating elevated real rates unfavorable for growth and deal-contingent names. Equity markets are risk-on (tech leading, Nasdaq up) following a September jobs miss, with recession odds priced at just 8% — an internally inconsistent signal that traders should flag as a potential market dislocation.